Lunit Inc.
Founded in 2013, Lunit provides AI-driven cancer screening and oncology solutions through Lunit INSIGHT and Lunit SCOPE.
As of 2026-10-10, Lunit Inc. has 2 MFDS Innovative Medical Device designations, 12 Korean MFDS device approvals, 6 US FDA clearances/approvals, 139 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2013 and listed on KOSDAQ in 2022, Lunit is a deep learning-based medical AI company. It provides the AI-assisted detection solution Lunit INSIGHT and the imaging biomarker solution Lunit SCOPE, distributed globally through partnerships with GE Healthcare, Philips, Fujifilm, and Hologic. Consolidated revenue reached KRW 83,129 million at the end of 2025 (8% domestic, 92% overseas), with over 3,600 institutions and 9,500 clinicians worldwide using its solutions to analyze roughly 19.7 million medical images annually.
Products & technology
- Lunit INSIGHTAI-assisted detection for cancer screening, including breast cancer
- Lunit SCOPEImaging biomarker for histopathology analysis and treatment response prediction
Regulatory approvals
data.go.kr · openFDA2 Innovative Medical Device designations · 2020–2021 / 12 Korean MFDS device approvals · 2018–2023 / 6 US FDA 510(k) · 2021–2026
- InnovativeLunit INSIGHT MMG 외 2건2021-09-02Innovative Medical Device designation
- InnovativeLunit INSIGHT CXR2020-09-18Innovative Medical Device designation
- FDALunit INSIGHT MMG (v1.1.10)2026-04-23
- FDALunit INSIGHT DBT (V1.2)2026-03-26
- FDALunit INSIGHT DBT v1.12024-10-04
- FDALunit INSIGHT DBT2023-11-06
- MFDSBreast cancer image, computer aided detection/ diagnosis software2023-01-17Product approval · Class 3제허 23-36 호
- MFDSProduct name not recorded2023-01-17Product approval · Class 3허 23-36 호
- MFDSComputer aided diagnosis software for pathological cells or tissueRevoked2022-06-20Product approval · Class 3체외 제허 22-395 호
- MFDSMedical image, computer aided detection/ diagnosis software, class 22022-02-16Product approval · Class 2제인 22-4113 호
- FDALunit INSIGHT MMG2021-11-17
- FDALunit INSIGHT CXR Triage2021-11-10
Show 8 more
- MFDSMedical image, computer aided detection/ diagnosis software, class 22020-10-19Product approval · Class 2제허 20-896 호
- MFDSProduct name not recorded2020-10-19Product approval · Class 2허 20-896 호
- MFDS의료영상검출보조소프트웨어2020-01-13Product approval · Class 2제허 20-24 호
- MFDSProduct name not recorded2020-01-13Product approval · Class 2허 20-24 호
- MFDS의료영상검출보조소프트웨어Revoked2019-10-21Product approval · Class 2제허 19-660 호
- MFDSBreast cancer image, computer aided detection/ diagnosis software2019-07-29Product approval · Class 3제허 19-493 호
- MFDSProduct name not recorded2019-07-29Product approval · Class 3허 19-493 호
- MFDS의료영상검출보조소프트웨어Revoked2018-08-14Product approval · Class 2제허 18-574 호
Global clinical trials
ClinicalTrials.gov · sponsor-matchedUnknown · 2024-02 · NCT06232070
Completed · 2022-03 · NCT05716958
Completed · 2021-06 · NCT05619029
Completed · 2020-06 · NCT05615298
Completed · 2020-02 · NCT05614232
Key disclosures
KRX KIND via OpenDARTShow 4 more events
Publications
PubMed · affiliation-matched- A Foundation Model of Cancer Genotype Enables Precise Predictions of Therapeutic Response.
Cancer discovery · 2026-10 · Kong J, Lee I, Boecher D 외 14
- Age-Dependent Role of Cough Hypersensitivity in Transition to Refractory Chronic Cough.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026-10 · Kang SY, Won HK, Kim MY 외 17
- Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial.
Nature medicine · 2026-09 · Lee CK, Chung T, Kim IH 외 16
- Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance.
Histopathology · 2026-09 · Koh J, Suh KJ, Park HY 외 16
- Comprehensive molecular profiling of combined hepatocellular carcinoma and cholangiocarcinoma reveals distinct Notch signaling subgroups with prognostic significance.
Virchows Archiv : an international journal of pathology · 2026-08 · Yang CM, Lim J, Noh MG 외 6
- Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.
British journal of haematology · 2026-08 · Kim WS, Kim SJ, Jo JC 외 14
- Patient-Anchored Cough Visual Analogue Scale and Leicester Cough Questionnaire Thresholds for Cough Control Classification in Chronic Cough.
Lung · 2026-07 · Suh M, Oh JY, Won HK 외 19
- Artificial intelligence-based prediction of claudin 18.2 expression and immune phenotype from routine histology to guide treatment decisions in patients with gastric cancer.
ESMO open · 2026-07 · Kim HD, Shin S, Hwang W 외 10
- Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors.
Journal for immunotherapy of cancer · 2026-06 · Derbala MH, Stephen B, Hwang W 외 19
- Synergistic Induction of Neutrophilic Inflammatory Programs by Staphylococcus aureus and Cigarette Smoke in Airway Epithelial Cells.
Immune network · 2026-06 · Won HK, Lee J, Yun JW 외 8
Show 129 more publications
- Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study.
Head & neck · 2026-05 · Chun SH, Seo S, Cho JH 외 9
- Artificial intelligence-powered H&E-based quantification of spatial tumor-infiltrating lymphocyte distribution identifies prognostic immune niches in colorectal cancer.
Cancer immunology, immunotherapy : CII · 2026-05 · Koh HH, Lee S, Oum C 외 7
- PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Oral surgery, oral medicine, oral pathology and oral radiology · 2026-05 · Kim DH, Koh J, Ahn JS 외 11
- The integrated stress response promotes immune evasion through lipocalin 2.
Nature · 2026-04 · Bossowski JP, Pillai R, Kilian J 외 33
- A Multicenter Pilot Randomized Controlled Trial of a Digital Symptom Management Platform (WECARE) for Gastric Cancer Survivors.
Cancers · 2026-04 · Song GJ, Min JS, Kim RB 외 11
- Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
JCO global oncology · 2026-04 · Keam B, Lim DW, Kao HF 외 15
- Current state of mammography-based artificial intelligence for future breast cancer risk prediction: a systematic review.
Journal of the National Cancer Institute · 2026-03 · Lowry KP, Jeong HE, Kim KH 외 5
- Subgroup performance of a commercial digital breast tomosynthesis model for breast cancer detection.
Nature communications · 2026-03 · Brown-Mulry B, Isaac RS, Lee SH 외 10
- Performance of a Screening Mammography AI Algorithm Repurposed for Symptomatic Mammography in a Tertiary Outpatient Clinic.
Diagnostics (Basel, Switzerland) · 2026-03 · Ngo H, Niller E, Schmitz E 외 8
- Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026-02 · McKelvey B, Torres-Saavedra PA, Li J 외 38
- Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.
PloS one · 2026-01 · Song SG, Cho SI, Sim T 외 11
- CEBPB Expression in Tumor Cells Drives Immune Evasion in Colorectal Cancer via CTLA4 Up-regulation in T Cells.
Cancer communications (London, England) · 2026-01 · Yun HJ, Park CH, Yun D 외 17
- Time-dependent Increase in Cortisol after 1-mg Overnight Dexamethasone Suppression Test in Adrenal Incidentalomas.
Journal of the Endocrine Society · 2026-01 · Ahn SH, Jung KY, Ahn CH 외 9
- Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence Variability.
Laboratory investigation; a journal of technical methods and pathology · 2026-01 · Kim H, Heo J, Cho SI 외 21
- Differential implications of tumor endothelial cell and lymphocyte densities in advanced hepatocellular carcinoma patients treated with immunotherapy.
NPJ precision oncology · 2025-12 · Kim G, Kang B, Hong JY 외 17
- Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer.
Cancer research communications · 2025-12 · Park J, Shin S, Hwang W 외 19
- OCELOT 2023: Cell detection from cell-tissue interaction challenge.
Medical image analysis · 2025-12 · Shin J, Ryu J, Puche AV 외 21
- Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.
JAMA oncology · 2025-11 · Hwang W, Ahn JS, Jung HA 외 2
- Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors.
Cancer research and treatment · 2025-11 · Ahn JS, Hong JY, Park JO 외 8
- Radiologist and AI Concordance in Screening Mammography and Association with Future Breast Cancer Risk.
Radiology. Artificial intelligence · 2025-11 · Kim EY, Park EK, Kwon MR 외 16
- Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Cancer Treated With Trastuzumab Plus Folinic Acid, Fluorouracil, and Oxaliplatin.
JCO precision oncology · 2025-10 · Kim H, Oum C, Cho SI 외 9
- Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21).
ESMO open · 2025-10 · Im SA, Park K, Koh J 외 32
- Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.
Journal for immunotherapy of cancer · 2025-10 · Bang YH, Park GH, Oh JW 외 16
- The efficacy of a symptom management platform among gastric cancer survivors: a study protocol for a randomized controlled trial.
International journal of surgery protocols · 2025-09 · Song JH, Lee J, Min JS 외 12
- Explainable machine learning models based on clinical trial surrogate outcomes for predicting overall survival in head and neck cancers.
ESMO open · 2025-09 · Hwang W, Jung HA, Worth LJ 외 1
- Comparative single-cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses.
Cancer communications (London, England) · 2025-09 · Baek S, Cha J, Hong MH 외 10
- Artificial Intelligence-Powered Spatial Analysis of Immune Phenotypes in Resected Pancreatic Cancer.
JAMA surgery · 2025-08 · Kim H, Choi JH, Lim Y 외 21
- Deciphering the intratumoral histologic heterogeneity of lung adenocarcinoma using radiomics.
European radiology · 2025-08 · Koo JM, Kim J, Lee J 외 8
- Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma.
Journal of thoracic disease · 2025-07 · Kim DH, Lim Y, Song S 외 11
- Machine learning-based classification of adrenal tumors using clinical, hormonal, and body composition data.
European journal of endocrinology · 2025-07 · Park SS, Noh J, Kim J 외 6
- Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in Patients With Triple-negative Breast Cancer.
Anticancer research · 2025-06 · Kim HG, Kang SY, Kim KM 외 8
- Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial.
EClinicalMedicine · 2025-06 · Kim J, Bang YH, Park S 외 18
- Robustness of automated acne lesion detection across various imaging conditions: A comparative analysis with dermatologists.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2025-05 · Lee JS, Han B, Lee H 외 5
- Early-Life Diet and Persistent Atopic Dermatitis: A Nationwide Cohort Study.
Allergy · 2025-05 · Lee JS, Kim SR, Kim DH 외 2
- Long-term observation to determine durable efficacy and safety of novel paediatric atopic dermatitis treatment, nemolizumab.
The British journal of dermatology · 2025-04 · Cho SI, Na JI
- Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors.
Cancer medicine · 2025-04 · Chae YK, Duan R, Chung LI 외 8
- Neoadjuvant Chemotherapy Response in Triple-Negative Apocrine Carcinoma: Comparing Apocrine Morphology, Androgen Receptor, and Immune Phenotypes.
Archives of pathology & laboratory medicine · 2025-04 · Hwang I, Lim Y, Song S 외 7
- Impact of Deep Learning-Based Computer-Aided Detection and Electronic Notification System for Pneumothorax on Time to Treatment: Clinical Implementation.
Journal of the American College of Radiology : JACR · 2025-04 · Oh SN, Yang H, Lee CK 외 4
- Healthcare Crisis in Korea and Its Impact on Medical Research: A PubMed Analysis (2022-2024).
Journal of Korean medical science · 2025-03 · Cho SI, Lee JM, Park HJ 외 2
- Concordant and discordant breast density patterns by different approaches for assessing breast density and breast cancer risk.
Breast cancer research and treatment · 2025-02 · Cho Y, Park EK, Chang Y 외 14
- Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) · 2025-02 · Hong TH, Hwang S, Abbosh C 외 12
- Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09).
Cancer · 2025-01 · Kim M, Kim YJ, Suh KJ 외 17
- Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.
JCO precision oncology · 2025-01 · Imai M, Nakamura Y, Shin S 외 17
- Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications.
ESMO open · 2025-01 · Park C, Kim R, Bae JM 외 11
- Poor prognostic factors independently impact remission and treatment escalation in rheumatoid arthritis regardless of disease activity: A nationwide prospective cohort study.
Joint bone spine · 2025-01 · Ha YJ, Shin S, Choi SR 외 3
- Clinical significance of concurrent TP53 mutations in KRAS-mutant invasive mucinous adenocarcinoma patients undergoing curative-intent lung surgery.
Cancer treatment and research communications · 2025-01 · Yoon DW, Hwang S, Lee B 외 8
- AI in Aesthetic/Cosmetic Dermatology: Current and Future.
Journal of cosmetic dermatology · 2025-01 · Thunga S, Khan M, Cho SI 외 2
- Deep learning for pediatric chest x-ray diagnosis: Repurposing a commercial tool developed for adults.
PloS one · 2025-01 · Agarwal P, Rau A, Ngo H 외 4
- Artificial Intelligence-Driven Quantification of Tumor-Stroma Ratio and Fibroblasts Enables Precise Classification of Stroma Quality and Quantity in Predicting Colorectal Cancer Recurrence.
Pathobiology : journal of immunopathology, molecular and cellular biology · 2025-01 · Jung M, Kim JY, Jeong H 외 4
- Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy.
JCO precision oncology · 2025-01 · Park JC, Ahn JS, Merkin R 외 3
- AI-assisted detection for chest X-rays (AID-CXR): a multi-reader multi-case study protocol.
BMJ open · 2024-12 · Khan F, Das I, Kotnik M 외 14
- A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types.
NPJ precision oncology · 2024-12 · Brattoli B, Mostafavi M, Lee T 외 14
- Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors.
Discover oncology · 2024-11 · Kim DH, Kang M, Park G 외 10
- Corrigendum to "Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18": [ESMO Open 8 (2023) 101588].
ESMO open · 2024-11 · Kim M, Lee JL, Shin SJ 외 10
- The Modified S-GRAS Scoring System for Prognosis in Korean with Adrenocortical Carcinoma.
Endocrinology and metabolism (Seoul, Korea) · 2024-10 · Baek SK, Lee SH, Park SS 외 11
- Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations.
European radiology · 2024-10 · Kim HJ, Kim HH, Kim KH 외 6
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2024-10 · Bang YH, Lee CK, Bang K 외 20
- Prediction of immunotherapy response using mutations to cancer protein assemblies.
Science advances · 2024-09 · Kong J, Zhao X, Singhal A 외 9
- Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy.
Cancers · 2024-09 · Hwang JE, Kim SS, Bang HJ 외 9
- Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment.
Cells · 2024-09 · Kim DH, Ahn JS, Kang M 외 11
- Prognostic Significance of the Immune Microenvironment in Endometrial Cancer.
Laboratory investigation; a journal of technical methods and pathology · 2024-09 · Lee M, Jung W, Kang J 외 5
- My career path at a medical artificial intelligence company, working as a physician outside of clinical practice.
Ewha medical journal · 2024-07 · Ahn CH
- Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study.
Journal of internal medicine · 2024-07 · Park SS, Ahn CH, Lee S 외 9
- An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability.
Histopathology · 2024-07 · Lee KS, Choi E, Cho SI 외 13
- Artificial Intelligence-Powered Imaging Biomarker Based on Mammography for Breast Cancer Risk Prediction.
Diagnostics (Basel, Switzerland) · 2024-06 · Park EK, Lee H, Kim M 외 6
- A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2024-05 · Kim CG, Hong MH, Kim D 외 34
- Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease.
The Journal of investigative dermatology · 2024-05 · Kim SR, Yu DA, Cho SI 외 1
- Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer.
JCO precision oncology · 2024-05 · Kim H, Kim S, Choi S 외 12
- Impact of AI for Digital Breast Tomosynthesis on Breast Cancer Detection and Interpretation Time.
Radiology. Artificial intelligence · 2024-05 · Park EK, Kwak S, Lee W 외 3
- Screening mammography performance according to breast density: a comparison between radiologists versus standalone intelligence detection.
Breast cancer research : BCR · 2024-04 · Kwon MR, Chang Y, Ham SY 외 14
- Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024-04 · Park S, Kim TM, Han JY 외 21
- Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population-based study.
The Journal of dermatology · 2024-03 · Yu DA, Kim SR, Cho SI 외 1
- Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
Journal for immunotherapy of cancer · 2024-02 · Shen J, Choi YL, Lee T 외 27
- Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases.
Breast cancer research : BCR · 2024-02 · Jung M, Song SG, Cho SI 외 17
- Reduced economic disparity in biologics use for psoriasis after introducing the reducing copayment program.
Scientific reports · 2024-02 · Jung H, Kim SR, Cho SI 외 1
- Understanding metric-related pitfalls in image analysis validation.
Nature methods · 2024-02 · Reinke A, Tizabi MD, Baumgartner M 외 67
- Artificial Intelligence for Assessment of Endotracheal Tube Position on Chest Radiographs: Validation in Patients From Two Institutions.
AJR. American journal of roentgenology · 2024-01 · An JY, Hwang EJ, Nam G 외 4
- Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis.
BMC cancer · 2024-01 · Shin S, Moon J, Oum C 외 5
- Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma.
Head & neck · 2023-12 · Kim DH, Lim Y, Ock CY 외 16
- Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer.
NPJ precision oncology · 2023-11 · Lim Y, Choi S, Oh HJ 외 14
- Generation of a Melanoma and Nevus Data Set From Unstandardized Clinical Photographs on the Internet.
JAMA dermatology · 2023-11 · Cho SI, Navarrete-Dechent C, Daneshjou R 외 5
- Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study.
Thoracic cancer · 2023-10 · Kim DH, Lim Y, Kim S 외 11
- Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine.
Journal of breast cancer · 2023-10 · Ahn JS, Shin S, Yang SA 외 5
- Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis.
Endocrine-related cancer · 2023-09 · Nam M, Yang W, Kim HS 외 8
- Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.
NPJ breast cancer · 2023-08 · Choi S, Cho SI, Jung W 외 11
- Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18.
ESMO open · 2023-08 · Kim M, Lee JL, Shin SJ 외 10
- Effect of Human-AI Interaction on Detection of Malignant Lung Nodules on Chest Radiographs.
Radiology · 2023-06 · Lee JH, Hong H, Nam G 외 2
- Transformer-based Deep Neural Network for Breast Cancer Classification on Digital Breast Tomosynthesis Images.
Radiology. Artificial intelligence · 2023-05 · Lee W, Lee H, Lee H 외 3
- Validation study of machine-learning chest radiograph software in primary and emergency medicine.
Clinical radiology · 2023-01 · van Beek EJR, Ahn JS, Kim MJ 외 1
- High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities.
Cancer research · 2022-11 · Roh W, Geffen Y, Cha H 외 10
- A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11).
Clinical cancer research : an official journal of the American Association for Cancer Research · 2022-10 · Jung HA, Park KU, Cho S 외 9
- Artificial Intelligence-Based Identification of Normal Chest Radiographs: A Simulation Study in a Multicenter Health Screening Cohort.
Korean journal of radiology · 2022-10 · Yoo H, Kim EY, Kim H 외 6
- Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms.
Diagnostics (Basel, Switzerland) · 2022-09 · Cho HG, Cho SI, Choi S 외 13
- Association of Artificial Intelligence-Aided Chest Radiograph Interpretation With Reader Performance and Efficiency.
JAMA network open · 2022-08 · Ahn JS, Ebrahimian S, McDermott S 외 13
- Cardiac segmentation on CT Images through shape-aware contour attentions.
Computers in biology and medicine · 2022-08 · Park S, Chung M
- Development and Validation of a Multimodal-Based Prognosis and Intervention Prediction Model for COVID-19 Patients in a Multicenter Cohort.
Sensors (Basel, Switzerland) · 2022-07 · Lee JH, Ahn JS, Chung MJ 외 7
- Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response.
European journal of cancer (Oxford, England : 1990) · 2022-07 · Choi S, Cho SI, Ma M 외 14
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022-06 · Park S, Ock CY, Kim H 외 26
- Improving the Performance of Radiologists Using Artificial Intelligence-Based Detection Support Software for Mammography: A Multi-Reader Study.
Korean journal of radiology · 2022-05 · Lee JH, Kim KH, Lee EH 외 6
- Artificial Intelligence-Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non-Small-Cell Lung Cancer.
The American journal of pathology · 2022-04 · Park J, Cho HG, Park J 외 7
- Corrigendum: Artificial Intelligence for Breast Cancer Screening in Mammography (AI-STREAM): A Prospective Multicenter Study Design in Korea Using AI-Based CADe/x.
Journal of breast cancer · 2022-04 · Chang YW, An JK, Choi N 외 4
- Mammographically occult breast cancers detected with AI-based diagnosis supporting software: clinical and histopathologic characteristics.
Insights into imaging · 2022-03 · Kim HJ, Kim HH, Kim KH 외 5
- Artificial Intelligence for Breast Cancer Screening in Mammography (AI-STREAM): A Prospective Multicenter Study Design in Korea Using AI-Based CADe/x.
Journal of breast cancer · 2022-02 · Chang YW, An JK, Choi N 외 4
- Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
Frontiers in immunology · 2022-01 · Park C, Jeong DY, Choi Y 외 7
- AI-based improvement in lung cancer detection on chest radiographs: results of a multi-reader study in NLST dataset.
European radiology · 2021-12 · Yoo H, Lee SH, Arru CD 외 9
- Effectiveness of radiologist training in improving reader agreement for Lung-RADS 4X categorization.
European radiology · 2021-11 · Kim H, Goo JM, Kim TJ 외 22
- Author Correction: Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients.
Scientific reports · 2021-10 · Cho SY, Lee JH, Ryu JM 외 7
- Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients.
Scientific reports · 2021-08 · Cho SY, Lee JH, Ryu JM 외 7
- Deep Learning Analysis of CT Images Reveals High-Grade Pathological Features to Predict Survival in Lung Adenocarcinoma.
Cancers · 2021-08 · Choi Y, Aum J, Lee SH 외 6
- Development and validation of a deep learning algorithm detecting 10 common abnormalities on chest radiographs.
The European respiratory journal · 2021-05 · Nam JG, Kim M, Park J 외 5
- Evaluation of a deep learning-based computer-aided detection algorithm on chest radiographs: Case-control study.
Medicine · 2021-04 · Choi SY, Park S, Kim M 외 3
- Impact of image compression on deep learning-based mammogram classification.
Scientific reports · 2021-04 · Jo YY, Choi YS, Park HW 외 7
- Deep learning-based automated detection algorithm for active pulmonary tuberculosis on chest radiographs: diagnostic performance in systematic screening of asymptomatic individuals.
European radiology · 2021-02 · Lee JH, Park S, Hwang EJ 외 6
- Sharing genetic variants with the NGS pipeline is essential for effective genomic data sharing and reproducibility in health information exchange.
Scientific reports · 2021-01 · Lee JH, Kweon S, Park YR
- Erratum: Correction of Author Name and Affiliation in the Article "Artificial Intelligence in Health Care: Current Applications and Issues".
Journal of Korean medical science · 2020-12 · Park CW, Seo SW, Kang N 외 20
- Artificial Intelligence in Health Care: Current Applications and Issues.
Journal of Korean medical science · 2020-11 · Park CW, Seo SW, Kang N 외 20
- Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
JAMA network open · 2020-09 · Yoo H, Kim KH, Singh R 외 2
- Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses.
Diagnostic pathology · 2020-07 · Pantanowitz L, Hartman D, Qi Y 외 8
- Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms.
JAMA network open · 2020-03 · Schaffter T, Buist DSM, Lee CI 외 70
- Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study.
The Lancet. Digital health · 2020-03 · Kim HE, Kim HH, Han BK 외 5
- Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea.
The American journal of gastroenterology · 2019-11 · Shin DW, Suh B, Lim H 외 6
- Development and Validation of a Deep Learning-based Automatic Detection Algorithm for Active Pulmonary Tuberculosis on Chest Radiographs.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019-08 · Hwang EJ, Park S, Jin KN 외 7
- Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge.
Medical image analysis · 2019-05 · Veta M, Heng YJ, Stathonikos N 외 30
- Development and Validation of a Deep Learning-Based Automated Detection Algorithm for Major Thoracic Diseases on Chest Radiographs.
JAMA network open · 2019-03 · Hwang EJ, Park S, Jin KN 외 9
- Development and Validation of Deep Learning-based Automatic Detection Algorithm for Malignant Pulmonary Nodules on Chest Radiographs.
Radiology · 2019-01 · Nam JG, Park S, Hwang EJ 외 8
- Risk of Coronary Heart Disease and Ischemic Stroke Incidence in Gastric Cancer Survivors: A Nationwide Study in Korea.
Annals of surgical oncology · 2018-10 · Shin DW, Suh B, Park Y 외 5
- J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018-06 · Shin DW, Suh B, Lim H 외 3
- Applying Data-driven Imaging Biomarker in Mammography for Breast Cancer Screening: Preliminary Study.
Scientific reports · 2018-02 · Kim EK, Kim HE, Han K 외 4
- Incidentally detected atherosclerosis in the abdominal aorta or its major branches on computed tomography is highly associated with coronary heart disease in asymptomatic adults.
Journal of cardiovascular computed tomography · 2018-01 · Suh B, Song YS, Shin DW 외 9
Patents
KIPRIS · applicant-matchedEP · Published · 2026-02 · Application 26158107.8
US · Published · 2026-02 · Application 19536488
US · Published · 2025-12 · Application 19437565
US · Published · 2025-12 · Application 19432487
Published · 2025-12 · Application 1020250210115
PCT · Published · 2025-12 · Application PCT/KR2025/021729
Published · 2025-12 · Application 1020250188990
US · Published · 2025-11 · Application 19381301
US · Published · 2025-10 · Application 19374026
Published · 2025-10 · Application 1020250157276
Show 218 more patents
PCT · Published · 2025-10 · Application PCT/KR2025/015661
US · Published · 2025-09 · Application 19345677
Published · 2025-09 · Application 1020250138927
PCT · Published · 2025-09 · Application PCT/KR2025/014466
Published · 2025-09 · Application 1020250127848
US · Published · 2025-08 · Application 19308527
US · Published · 2025-05 · Application 19211527
PCT · Published · 2025-05 · Application PCT/KR2025/006276
US · Published · 2025-04 · Application 19174155
US · Published · 2025-03 · Application 19070944
US · Published · 2025-02 · Application 19044990
EP · Published · 2025-02 · Application 25155774.0
US · Published · 2025-01 · Application 19034933
PCT · Published · 2025-01 · Application PCT/KR2025/099135
Published · 2025-01 · Application 1020267014683
US · Published · 2025-01 · Application 19017915
US · Published · 2024-12 · Application 19000942
PCT · Published · 2024-12 · Application PCT/KR2024/021056
US · Published · 2024-12 · Application 18989234
Published · 2024-12 · Application 1020240193383
Published · 2024-12 · Application 1020240188819
US · Published · 2024-11 · Application 18946457
Published · 2024-10 · Application 1020240151239
Published · 2024-10 · Application 1020240145339
Withdrawn · 2024-10 · Application 1020240133931
Published · 2024-09 · Application 1020240132439
EP · Published · 2024-09 · Application 24203402.3
US · Published · 2024-09 · Application 18892633
Registered · 2024-09 · Application 1020240128141
Published · 2024-08 · Application 1020240117963
US · Published · 2024-08 · Application 18799341
Published · 2024-08 · Application 1020240106457
Published · 2024-06 · Application 1020240073571
Published · 2024-05 · Application 1020240069851
Published · 2024-05 · Application 1020240068620
EP · Published · 2024-05 · Application 24177403.3
PCT · Published · 2024-05 · Application PCT/KR2024/006848
PCT · Published · 2024-05 · Application PCT/KR2024/006853
EP · Published · 2024-05 · Application 24819494.6
PCT · Published · 2024-05 · Application PCT/KR2024/006298
EP · Published · 2024-04 · Application 24811461.3
PCT · Published · 2024-04 · Application PCT/KR2024/095662
EP · Published · 2024-04 · Application 24167982.8
Published · 2024-02 · Application 1020240016863
US · Published · 2024-01 · Application 18416285
Published · 2024-01 · Application 1020240007681
EP · Published · 2024-01 · Application 24151197.1
EP · Published · 2024-01 · Application 24744764.2
PCT · Published · 2024-01 · Application PCT/KR2024/000073
US · Published · 2023-12 · Application 18532572
US · Published · 2023-12 · Application 18528923
Published · 2023-11 · Application 1020230159411
US · Published · 2023-11 · Application 18506741
EP · Published · 2023-11 · Application 23209046.4
Published · 2023-11 · Application 1020230149215
Published · 2023-10 · Application 1020230143367
Published · 2023-10 · Application 1020230138057
Published · 2023-09 · Application 1020230124029
Published · 2023-09 · Application 1020230124028
Published · 2023-09 · Application 1020230122617
Published · 2023-07 · Application 1020230096687
US · Published · 2023-06 · Application 18334836
EP · Published · 2023-06 · Application 23179154.2
Registered · 2023-06 · Application 1020230072404
Published · 2023-05 · Application 1020230068642
Published · 2023-05 · Application 1020230067013
EP · Published · 2023-05 · Application 23174891.4
Registered · 2023-03 · Application 1020230038276
Published · 2023-03 · Application 1020230036368
EP · Published · 2023-03 · Application 23161701.0
Registered · 2023-03 · Application 1020230033546
EP · Published · 2023-02 · Application 23763647.7
PCT · Published · 2023-02 · Application PCT/KR2023/002241
Published · 2023-02 · Application 1020230017338
EP · Published · 2023-02 · Application 23155596.2
Published · 2023-01 · Application 1020230010383
Registered · 2022-12 · Application 1020220176781
PCT · Published · 2022-12 · Application PCT/KR2022/020223
Published · 2022-11 · Application 1020220159657
Published · 2022-11 · Application 1020220156241
US · Published · 2022-11 · Application 18056773
EP · Published · 2022-11 · Application 22206669.8
EP · Published · 2022-11 · Application 22922334.2
PCT · Published · 2022-11 · Application PCT/KR2022/017052
Published · 2022-10 · Application 1020220127411
Registered · 2022-08 · Application 1020220105464
PCT · Published · 2022-08 · Application PCT/KR2022/012061
Published · 2022-08 · Application 1020220100254
Registered · 2022-08 · Application 1020220097366
EP · Published · 2022-08 · Application 22856084.3
PCT · Published · 2022-08 · Application PCT/KR2022/011308
Registered · 2022-08 · Application 1020220095389
Published · 2022-07 · Application 1020220093637
EP · Published · 2022-07 · Application 22842497.4
PCT · Published · 2022-07 · Application PCT/KR2022/010321
Published · 2022-07 · Application 1020220087202
US · Published · 2022-07 · Application 17858330
Registered · 2022-06 · Application 1020220071642
EP · Published · 2022-05 · Application 22849678.2
PCT · Published · 2022-05 · Application PCT/KR2022/006463
- METHOD AND APPARATUS FOR PROVIDING CONFIDENCE INFORMATION ON RESULT OF ARTIFICIAL INTELLIGENCE MODEL
EP · Published · 2022-03 · Application 22781624.6
EP · Published · 2022-03 · Application 22781625.3
- METHOD AND APPARATUS FOR PROVIDING CONFIDENCE INFORMATION ON RESULT OF ARTIFICIAL INTELLIGENCE MODEL
PCT · Published · 2022-03 · Application PCT/KR2022/004544
PCT · Published · 2022-03 · Application PCT/KR2022/004546
Published · 2022-03 · Application 1020220038925
Published · 2022-03 · Application 1020220038924
PCT · Published · 2022-03 · Application PCT/KR2022/004054
Published · 2022-03 · Application 1020220028108
Published · 2022-02 · Application 1020220022243
US · Published · 2022-02 · Application 18270895
EP · Published · 2022-02 · Application 22752992.2
PCT · Published · 2022-02 · Application PCT/KR2022/002008
Published · 2022-02 · Application 1020220017203
EP · Published · 2022-02 · Application 22788241.2
PCT · Published · 2022-02 · Application PCT/KR2022/001892
PCT · Published · 2022-01 · Application PCT/KR2022/001147
Published · 2022-01 · Application 1020220005540
US · Published · 2021-12 · Application 17551506
US · Published · 2021-11 · Application 17521008
EP · Published · 2021-11 · Application 21802585.6
PCT · Published · 2021-11 · Application PCT/KR2021/015734
US · Published · 2021-10 · Application 17502661
Registered · 2021-09 · Application 1020210120991
Registered · 2021-09 · Application 1020210120993
Rejected · 2021-07 · Application 1020210100989
US · Published · 2021-07 · Application 17383937
EP · Registered · 2021-06 · Application 24223267.6
Registered · 2021-05 · Application 1020210064086
EP · Published · 2021-05 · Application 21809543.8
PCT · Published · 2021-05 · Application PCT/KR2021/006163
Published · 2021-05 · Application 1020210063464
EP · Published · 2021-05 · Application 21803570.7
PCT · Published · 2021-05 · Application PCT/KR2021/006034
Published · 2021-05 · Application 1020210062294
EP · Registered · 2021-05 · Application 21800882.9
EP · Published · 2021-05 · Application 21800694.8
PCT · Published · 2021-05 · Application PCT/KR2021/005771
Registered · 2021-05 · Application 1020210059519
Registered · 2021-05 · Application 1020210059537
Registered · 2021-04 · Application 1020210047603
Registered · 2021-04 · Application 1020210047446
Registered · 2021-03 · Application 1020210034111
Registered · 2021-03 · Application 1020210029223
Registered · 2021-02 · Application 1020210014945
Registered · 2021-01 · Application 1020210007188
Registered · 2021-01 · Application 1020210007191
Registered · 2021-01 · Application 1020210007193
Registered · 2021-01 · Application 1020210007637
PCT · Published · 2020-12 · Application PCT/KR2020/018348
Expired · 2020-11 · Application 1020200164421
Registered · 2020-11 · Application 1020200148939
Registered · 2020-11 · Application 1020200144411
PCT · Published · 2020-09 · Application PCT/KR2020/013027
Registered · 2020-09 · Application 1020200124142
Registered · 2020-09 · Application 1020200122591
Registered · 2020-07 · Application 1020200087227
Registered · 2020-06 · Application 1020200072257
Registered · 2020-06 · Application 1020200068956
PCT · Published · 2020-05 · Application PCT/KR2020/007054
Registered · 2020-05 · Application 1020200065500
Registered · 2020-05 · Application 1020200061345
Registered · 2020-05 · Application 1020200061582
Registered · 2020-05 · Application 1020200059363
Registered · 2020-04 · Application 1020200052601
US · Published · 2020-03 · Application 16832142
Registered · 2020-03 · Application 1020200034456
Registered · 2020-03 · Application 1020200034436
Registered · 2020-02 · Application 1020200025445
Registered · 2020-02 · Application 1020200022368
Registered · 2020-02 · Application 1020200016770
Registered · 2020-02 · Application 1020200017255
Registered · 2020-01 · Application 1020200011129
Registered · 2020-01 · Application 1020200009995
Registered · 2020-01 · Application 1020200007785
Registered · 2020-01 · Application 1020200004863
CN · Published · 2019-12 · Application 201911395855.8
JP · Registered · 2019-12 · Application 31229213
Registered · 2019-12 · Application 1020190168111
Registered · 2019-11 · Application 1020190157255
Registered · 2019-11 · Application 1020190144442
Registered · 2019-11 · Application 1020190144441
Registered · 2019-11 · Application 1020190144431
Expired · 2019-10 · Application 1020190135420
Registered · 2019-10 · Application 1020190134348
Expired · 2019-10 · Application 1020190128092
Registered · 2019-10 · Application 1020190127085
Registered · 2019-10 · Application 1020190123067
Registered · 2019-10 · Application 1020190123098
Registered · 2019-09 · Application 1020190109855
Registered · 2019-09 · Application 1020190109151
Registered · 2019-05 · Application 1020190059860
Registered · 2019-05 · Application 1020190058905
Registered · 2019-04 · Application 1020190049694
Registered · 2019-04 · Application 1020190045836
Expired · 2019-04 · Application 1020190039033
Registered · 2019-04 · Application 1020190038145
Expired · 2019-04 · Application 1020190038321
Expired · 2019-04 · Application 1020190038197
Registered · 2019-03 · Application 1020190032699
Registered · 2019-03 · Application 1020190032120
Registered · 2019-03 · Application 1020190031664
Expired · 2019-03 · Application 1020190031662
Registered · 2019-03 · Application 1020190031099
JP · Registered · 2018-11 · Application 32528015
Registered · 2018-11 · Application 1020180137347
Registered · 2018-11 · Application 1020180137355
Registered · 2018-07 · Application 1020180077424
Registered · 2018-07 · Application 1020180077425
Registered · 2018-07 · Application 1020180077423
Registered · 2017-02 · Application 1020170018936
Expired · 2016-11 · Application 1020160156041
Registered · 2016-11 · Application 1020160156035
Rejected · 2015-10 · Application 1020150147050
Expired · 2015-09 · Application 1020150128420
US · Published · 2015-09 · Application 15113680
Registered · 2015-08 · Application 1020150111277
Registered · 2015-04 · Application 1020150055167
Expired · 2013-12 · Application 1020130152089
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive5
- OpenAIOAI-SearchBot79
- GoogleGoogleOther6
- PerplexityPerplexityBot3
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 25, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Lunit Inc. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical AI
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 2008 and listed on KOSDAQ in 2021, DEEPNOID develops medical and industrial AI imaging solutions like DEEP:NEURO.
Founded in 2012, Coreline Soft provides the AI-based chest CT diagnostic aid suite AVIEW for lung nodules, COPD, and coronary calcification.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
KOSDAQ-listed X-ray imaging solution company with a full lineup of medical, dental, veterinary, and industrial X-ray detectors.
Founded in 2014, VUNO provides AI-based vital-sign and medical imaging diagnostic solutions, including VUNO Med-DeepCARS and VUNO Med-Fundus AI.
Founded in 2009, SEERS provides the wearable ECG analysis solution mobiCARE and the inpatient monitoring solution thynC, based on AI vital-sign analytics.
Founded in 2002, INFINITT Healthcare provides PACS-centered medical imaging software and AI diagnostic aids across multiple clinical specialties.
Founded in 2009, SyntekaBio provides genomic big data-based AI drug discovery platforms DeepMatcher and NEO-ARS, along with the NGS-ARS precision medicine service.
JLK offers the stroke AI solution MEDIHUB STROKE and holds 78 global regulatory approvals, including US FDA and Japan PMDA clearances.
Founded in 2011, Acryl provides the integrated AI platform Jonathan and the healthcare-specialized AI platform Nadia.
Founded in 2017 and listed on KOSDAQ in 2026, Lemon Healthcare operates the LDB medical mydata relay platform for hospitals and insurers.
SELVAS AI provides voice and language AI technologies through its HCI and AI Digital Transformation business units.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition